🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/09/2001 | 36,83 | 37,95 | 36,16 | 37,13 | +2,37% | 4,88% | 22.068 |
| 04/09/2001 | 38,03 | 38,37 | 36,23 | 36,27 | -5,46% | 5,61% | 43.521 |
| 31/08/2001 | 36,87 | 38,48 | 36,87 | 38,37 | +2,50% | 4,37% | 28.827 |
| 30/08/2001 | 37,58 | 37,77 | 36,79 | 37,43 | -0,30% | 2,59% | 20.251 |
| 29/08/2001 | 37,80 | 37,99 | 36,49 | 37,54 | -0,10% | 3,96% | 24.953 |
| 28/08/2001 | 38,03 | 38,74 | 37,54 | 37,58 | -2,14% | 3,15% | 31.419 |
| 27/08/2001 | 38,74 | 38,74 | 37,88 | 38,40 | -0,58% | 2,22% | 32.274 |
| 24/08/2001 | 37,62 | 38,67 | 37,43 | 38,63 | +2,58% | 3,28% | 56.719 |
| 23/08/2001 | 38,44 | 38,78 | 37,62 | 37,65 | -1,95% | 3,02% | 23.324 |
| 22/08/2001 | 35,63 | 38,40 | 35,03 | 38,40 | +8,23% | 9,45% | 26.797 |
| 21/08/2001 | 35,52 | 37,80 | 34,81 | 35,48 | -0,84% | 8,43% | 46.086 |
| 20/08/2001 | 36,49 | 37,21 | 34,29 | 35,78 | -1,54% | 8,00% | 53.407 |
| 17/08/2001 | 37,54 | 38,18 | 36,31 | 36,34 | -5,73% | 4,99% | 15.896 |
| 16/08/2001 | 36,87 | 38,55 | 36,31 | 38,55 | +3,83% | 6,09% | 26.156 |
| 15/08/2001 | 37,80 | 38,22 | 36,57 | 37,13 | -2,75% | 4,36% | 17.526 |
| 14/08/2001 | 38,55 | 38,55 | 37,80 | 38,18 | -0,97% | 1,94% | 21.293 |
| 13/08/2001 | 35,75 | 38,55 | 35,75 | 38,55 | +3,00% | 7,85% | 24.018 |
| 10/08/2001 | 37,62 | 37,95 | 35,82 | 37,43 | -0,60% | 5,67% | 16.965 |
| 09/08/2001 | 37,43 | 37,65 | 35,60 | 37,65 | +0,30% | 5,50% | 21.373 |
| 08/08/2001 | 37,62 | 38,37 | 37,06 | 37,54 | +0,20% | 3,48% | 24.713 |
| 07/08/2001 | 38,07 | 38,55 | 36,68 | 37,47 | -1,86% | 4,92% | 42.453 |
| 06/08/2001 | 37,88 | 38,55 | 37,43 | 38,18 | +0,30% | 2,96% | 29.602 |
| 03/08/2001 | 38,44 | 38,70 | 37,24 | 38,07 | -1,36% | 3,80% | 26.476 |
| 02/08/2001 | 38,40 | 39,30 | 37,99 | 38,59 | +2,18% | 3,41% | 149.159 |
| 01/08/2001 | 37,65 | 38,55 | 37,32 | 37,77 | +0,40% | 3,28% | 37.858 |
| 31/07/2001 | 37,39 | 38,55 | 37,24 | 37,62 | +0,50% | 3,50% | 33.022 |
| 30/07/2001 | 37,77 | 37,77 | 37,09 | 37,43 | -0,10% | 1,78% | 26.637 |
| 27/07/2001 | 37,39 | 38,55 | 37,02 | 37,47 | +0,20% | 4,10% | 33.797 |
| 26/07/2001 | 35,18 | 37,88 | 35,18 | 37,39 | +6,28% | 7,66% | 36.335 |
| 25/07/2001 | 36,12 | 36,49 | 35,00 | 35,18 | -4,18% | 4,15% | 37.777 |